CliffBio
small molecule

ATENOLOL AND CHLORTHALIDONE

ATENOLOL; CHLORTHALIDONE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameATENOLOL AND CHLORTHALIDONE
Active ingredientATENOLOL; CHLORTHALIDONE
Strength50MG;25MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2021
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.